The mechanisms that promote obesity‐related metabolic complications are multifactorial and include insulin resistance, adverse fat distribution, altered adipokine secretion, subclinical chronic metabolic inflammation and impaired AT dysfunction (Table 1). This evidence concerns the gene INS and obesity disorder.